Achyut Bhattacharyya
Overview
Explore the profile of Achyut Bhattacharyya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
568
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larson K, Russ A, Arif-Tiwari H, Mahadevan D, Elliott A, Bhattacharyya A, et al.
J Immunother
. 2022 Jan;
45(4):222-226.
PMID: 35020691
Malignant peripheral nerve sheath tumors (MPNSTs) represent a rare subtype of neural crest cell-derived soft tissue sarcomas (STS). Standard of care therapy comprises surgical resection followed by adjuvant radiation, and...
2.
Thompson P, Ashbeck E, Roe D, Fales L, Buckmeier J, Wang F, et al.
J Natl Cancer Inst
. 2016 Aug;
108(12).
PMID: 27530657
Background: Selenium supplementation may help to prevent colorectal cancer; as precursors of colorectal cancer, colorectal adenomas are a surrogate for colorectal cancer. Selenium supplementation may increase risk of type 2...
3.
Thompson P, Ashbeck E, Roe D, Fales L, Buckmeier J, Wang F, et al.
J Natl Cancer Inst
. 2016 Aug;
108(12).
PMID: 27530656
Background: Cyclooxygenase (COX)-2 inhibitors such as celecoxib were designed to preserve anti-inflammatory activity without inhibiting COX-1. Downregulation of COX-2 inhibits colorectal carcinogenesis. Methods: The Selenium and Celecoxib Trial was a...
4.
Brand J, Furenlid L, Altbach M, Galons J, Bhattacharyya A, Sharma P, et al.
J Med Imaging (Bellingham)
. 2016 Jul;
3(3):035502.
PMID: 27446971
Chronic liver disease is a worldwide health problem, and hepatic fibrosis (HF) is one of the hallmarks of the disease. The current reference standard for diagnosing HF is biopsy followed...
5.
Thompson P, Roe D, Fales L, Buckmeier J, Wang F, Hamilton S, et al.
Cancer Prev Res (Phila)
. 2012 Oct;
5(12):1381-93.
PMID: 23060037
COX inhibitors reduce colorectal adenoma recurrence by up to 45% and selenium supplementation may prevent colorectal cancer. Following colonoscopic adenoma resection, 1,600 men and women, ages 40 to 80 years,...
6.
Wen F, Shen A, Shanas R, Bhattacharyya A, Lian F, Hostetter G, et al.
Ann Surg Oncol
. 2010 May;
17(10):2619-27.
PMID: 20499280
Background: The heterogeneous nuclear ribonucleoprotein (hnRNP) K is an essential RNA and DNA binding protein involved in gene expression and signal transduction. The role of hnRNP K in cancer is...
7.
Bartley A, Thompson P, Buckmeier J, Kepler C, Hsu C, Snyder M, et al.
Mod Pathol
. 2009 Oct;
23(2):169-76.
PMID: 19855374
Serrated polyps of the colorectal mucosa represent a heterogeneous and controversial taxonomic category with variation in histopathological, molecular, and immunohistochemical characteristics and with an incomplete understanding of pathogenesis. A previous...
8.
Zhou R, Shanas R, Nelson M, Bhattacharyya A, Shi J
Int J Cancer
. 2009 Jul;
126(2):395-404.
PMID: 19609950
The heterogeneous nuclear ribonucleoprotein (hnRNP) K is an essential RNA and DNA binding protein involved in gene expression and signal transduction including DNA transcription, RNA splicing, RNA stability and translation....
9.
Nguyen D, El-Serag H, Henderson L, Stein D, Bhattacharyya A, Sampliner R
Clin Gastroenterol Hepatol
. 2009 Jun;
7(12):1299-304.
PMID: 19523538
Background & Aims: Experimental evidence indicates that proton pump inhibitors (PPIs), nonsteroidal anti-inflammatory drugs (NSAIDs)/aspirin, and statins can protect patients with Barrett's esophagus (BE) from developing neoplasias. However, only limited...
10.
Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, et al.
Cancer Res
. 2009 May;
69(10):4112-5.
PMID: 19435894
Esophageal adenocarcinoma risk in Barrett's esophagus (BE) is increased 30- to 125-fold versus the general population. Among all BE patients, however, neoplastic progression occurs only once per 200 patient-years. Molecular...